Tissue Regenix (GB:TRX) has released an update.
Tissue Regenix Group PLC has solidified its growth strategy by purchasing the building it was leasing in Universal City, TX, securing a cost-effective path for its Phase 2 expansion plan. This strategic acquisition aligns with their sustainable growth pursuit and is expected to provide significant cost savings over time. The move is anticipated to enhance the company’s capacity for producing revolutionary regenerative medical devices, with the expansion set to complete in 2025.
For further insights into GB:TRX stock, check out TipRanks’ Stock Analysis page.
